Lupron and the Allure of a Lifetime Client
Investors love subscription services...
The “trans” project has a lot of arms, and one of the most powerful is the pharmaceutical industry. Selling medication to those who need it, which is honorable and necessary, just doesn’t make them enough money. The firms and their investors need to create markets. Read the excellent book, Empire of Pain: The Secret History of the Sackler Family to learn how this dynamic contributed to the opioid crisis.
What does that have to do with trans? There wasn’t a lot of market for chemical castration drugs until they were rebranded as “care” and renamed puberty blockers. Suddenly, there was a brand new market of lifetime clients for an obscure drug.
Lupron is that drug, and our friend Margot O’hlfearnain wrote the essay The Lupron Legacy about what it means to normalize the use of this drug on young people. Read it and share it.